Consolidated Statements of Cash Flows (USD $) | | |
In Millions | 9 Months Ended
Sep. 30, 2009
| 9 Months Ended
Sep. 30, 2008
|
Cash Flows from Operating Activities | | |
Net income | $463 | $307 |
Adjustments to reconcile net income to net cash (used in) provided by operating activities: | | |
Capitalization of deferred acquisition and sales inducement costs | (560) | (543) |
Amortization of deferred acquisition and sales inducement costs | 95 | 599 |
Depreciation, amortization and accretion, net | 101 | 214 |
Deferred income tax expense (benefit) | 103 | (187) |
Share-based compensation | 138 | 114 |
Net realized investment gains | (132) | (5) |
Other-than-temporary impairments recognized in net investment income and provision for loan losses | 107 | 380 |
Changes in operating assets and liabilities: | | |
Segregated cash | 82 | (663) |
Trading securities and equity method investments, net | 253 | 115 |
Future policy benefits and claims, net | 294 | 341 |
Receivables | (207) | (588) |
Brokerage deposits | 23 | 834 |
Accounts payable and accrued expenses | (128) | (413) |
Liability for derivatives collateral held | (1,659) | (102) |
Other, net | 89 | (214) |
Net cash (used in) provided by operating activities | (938) | 189 |
Available-for-Sale securities: | | |
Proceeds from sales | 3,910 | 316 |
Maturities, sinking fund payments and calls | 4,375 | 2,864 |
Purchases | (14,497) | (2,393) |
Proceeds from sales and maturities of commercial mortgage loans | 235 | 265 |
Funding of commercial mortgage loans | (83) | (88) |
Proceeds from sales of other investments | 47 | 40 |
Purchase of other investments | (14) | (345) |
Purchase of land, buildings, equipment and software | (56) | (100) |
Change in policy loans, net | 9 | (26) |
Change in restricted cash | 16 | 151 |
Change in consumer banking loans and credit card receivables, net | (107) | (60) |
Other, net | | 3 |
Net cash (used in) provided by investing activities | (6,165) | 627 |
Investment certificates and banking time deposits: | | |
Proceeds from additions | 2,141 | 1,813 |
Maturities, withdrawals and cash surrenders | (2,515) | (1,033) |
Change in other banking deposits | 1,157 | (87) |
Policyholder and contractholder account values: | | |
Consideration received | 4,386 | 1,569 |
Net transfers from separate accounts | 174 | |
Surrenders and other benefits | (1,587) | (2,223) |
Deferred premium options, net | (38) | (40) |
Proceeds from issuance of common stock, net of issuance costs | 869 | |
Proceeds from issuance of debt, net of issuance costs | 553 | 73 |
Repayments of debt | (550) | (6) |
Dividends paid to shareholders | (118) | (105) |
Repurchase of common shares | (9) | (636) |
Exercise of stock options | 1 | 9 |
Excess tax benefits from share-based compensation | 12 | 7 |
Noncontrolling interests investments in subsidiaries | 7 | 108 |
Distributions to noncontrolling interests | (42) | (33) |
Other, net | (2) | (1) |
Net cash provided by (used in) financing activities | 4,439 | (585) |
Effect of exchange rate changes on cash | 16 | (24) |
Net increase (decrease) in cash and cash equivalents | (2,648) | 207 |
Cash and cash equivalents at beginning of period | 6,228 | 3,836 |
Cash and cash equivalents at end of period | 3,580 | 4,043 |
Supplemental Disclosures: | | |
Interest paid on debt | 84 | 61 |
Income taxes paid, net | $13 | $165 |